This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Beijing Jiaotong University, Beijing Zhifei Lvzhu Biopharmaceutical Co. Ltd. Active years: 2025.
Company Filing History:
1 out of 64 
1 out of 1 Years Active: 2025
Title: Meiqin Liu: Innovator in Vaccine Development
Introduction
Meiqin Liu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of biopharmaceuticals, particularly in vaccine development. Her work focuses on combating respiratory infections, which are a major health concern worldwide.
Latest Patents
Meiqin Liu holds a patent for a "Combined Vaccine Against Human Respiratory Syncytial Virus (RSV) Infections and Method Thereof for Inducing Immune Response." This innovative vaccine aims to provide a robust immune response against RSV, which is known to cause severe respiratory illness, especially in infants and the elderly. The patent highlights her commitment to advancing public health through scientific research.
Career Highlights
Throughout her career, Meiqin Liu has worked with esteemed institutions such as Beijing Jiaotong University and Beijing Zhifei Lvzhu Biopharmaceutical Co. Ltd. Her roles in these organizations have allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Meiqin Liu has collaborated with notable colleagues, including Lin Du and Yuanhui Fu. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in vaccine technology.
Conclusion
Meiqin Liu's contributions to vaccine development exemplify her dedication to improving global health. Her innovative work continues to inspire future advancements in the field of biopharmaceuticals.